Huh, Young Eun
Park, Hyejung
Chiang, Ming Sum Ruby http://orcid.org/0000-0002-1484-5405
Tuncali, Idil http://orcid.org/0000-0001-7437-285X
Liu, Ganqiang http://orcid.org/0000-0002-1921-9542
Locascio, Joseph J.
Shirvan, Julia
Hutten, Samantha J.
Rotunno, Melissa S.
Viel, Catherine
Shihabuddin, Lamya S.
Wang, Bing
Sardi, Sergio Pablo
Scherzer, Clemens R. http://orcid.org/0000-0002-0567-9193
Funding for this research was provided by:
The Michael J. Fox Foundation APDA Center for Advanced Parkinson Research
Article History
Received: 14 January 2021
Accepted: 7 October 2021
First Online: 22 November 2021
Competing interests
: H.P., M.S.R.C., M.S.R., C.V., L.S.S., B.W., and S.P.S. are Sanofi employees. J.S. is currently a Biogen employee. C.R.S. and S.P.S. are named as co-inventors on a US patent application on <i>GBA</i> pathway biomarkers that is jointly held by Brigham & Women’s Hospital and Sanofi. C.R.S. is a consultant for Sanofi. The remaining authors declare no competing interests.